Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.

Skip to Content

Bipartisan Legislation In Support of Copay Assistance Counting For Patients

Published Date: February 16, 2023

STATEMENT FROM NCODA LEGISLATIVE & POLICY ADVISORY COMMITTEE (LPAC)
www.ncoda.org

February 16, 2023

On February 9, 2023, US Representatives Earl L. “Buddy” Carter (R-GA), Nanette Barragan (D-CA), Mariannette Miller-Meeks (R-IA), and Diana DeGette (D-CO) introduced the Help Ensure Lower Patient (HELP) Copays Act to the House floor. This bill aims to prohibit pharmacy benefit managers (PBMs) from utilizing “copay accumulator” schemes.

This bipartisan bill would require PBMs to count cost-sharing assistance towards a patient’s deductible or out-of-pocket maximum. This means that patients are less likely to be required to spend more than anticipated on prescription medication, and PBMs will not be able to pocket any money from copay assistance. As a result, the financial burden due to high medication costs on patients and their families will be alleviated.

This bill falls in line with sixteen other states and Puerto Rico, who have been actively working towards ensuring that copay assistance counts towards patients’ out-of-pocket costs. With the introduction of this bill on the House floor, more states can take notice of this issue and look to address it.

NCODA has been outspoken regarding PBMs and the effect that they have on patient access to care. We believe that revamping the PBM system is a priority to ensure that all patients are able to receive access to quality and affordable treatment. We applaud Representative Carter and every representative who has taken this step to bring awareness to this issue. NCODA, along with the Patient Access Network (PAN) Foundation co – authored a letter in support of this bill late last year. The bill had to be re-introduced due to the death of the bills former sponsor. Read press release HERE.

NCODA will continue our Mission to support patients and practices. Our organization and staff will remain firmly focused on this issue, and as we will continue our analysis of this and other important decisions as more information becomes available. To learn more about active laws and/or enacted legislation regarding copay accumulators, view NCODA’s Oncology Legislation Tracker here: www.ncoda.org/oncology-legislation-tracker.

# # #

About NCODA

NCODA is a leading nonprofit organization dedicated to empowering medically integrated oncology practices to deliver positive, patient-centered outcomes by providing leadership, expertise, quality standards, and best practices. For more information about NCODA visit www.ncoda.org or follow @NCODA on LinkedIn.